Calculus VCT plc, formerly known as Investec Structured Products Calculus VCT PLC, is a venture capital trust specializing in venture capital investments.

Calculus VCT plc

Calculus Capital is a company that offers EIS and VCT investment products, focusing on backing businesses across the fastest growing sectors of the UK economy including technology, healthcare and the environment.

Calculus Capital

Calculus specialises in creating and managing venture capital funds for individuals. Calculus is a pioneer in the tax-efficient industry having set up the UK’s first approved EIS fund in 1999. Through the Calculus EIS Fund, Calculus VCT and Calculus Knowledge EIS Fund - investors can access a diverse portfolio of innovative UK companies.

Important note: EIS and VCT investments are high risk and capital is at risk. Past performance is not indicative of future performance. Tax benefits depend on the individual circumstances of each investor and may be subject to change in the future.

Calculus Capital is authorised and regulated by the Financial Conduct Authority.

Synpromics Ltd

Scancell

Yourgene Health

Epistem

Arecor

Money Dashboard

C4X Discovery

Avvio

Horizon Discovery

Human Race

Inspiresport

Cloud Trade

Collagen Solutions

I am very pleased to announce Calculus' takeover of Great Point Media’s film and television production finance business, Illium. Illium has solid potential as an ongoing business providing secured financing for film and TV productions. We look forward to working closely with producers and our shareholders. Thanks to our incredible Calculus team for all their hard work over many weeks to make this possible.

How can investors prepare for a new political landscape? Read our election response, by Director Matthew Moynes here ⬇ 

https://lnkd.in/emxv2awK

The first Calculus Knowledge Intensive EIS Fund has been successfully fully deployed in just 11 months, we now have an exciting and diverse portfolio of healthcare and technology companies. 

'We focus on those companies which are the ‘doers,’ the innovators, the experts and the game changers.'

Congratulations on your BAFTA nomination for Evacuation, Wonderhood Studios 🏆 
We are so proud of the calibre of companies within our entertainment portfolio and the award nominations are a very well deserved endorsement.

Yesterday marked International Day of Women and Girls in Science, a celebration of the women who are blazing ahead to tackle the world’s toughest health challenges and discovering new scientific innovations.

We want to take this opportunity to thank and celebrate the inspirational women driving progress and innovation in #STEM, here at the Arecor Group and around the world.

Hear from some of the brilliant women working at Arecor Group, including our CEO Sarah Howell, and what it means to be a part of a successful women-led and diverse company culture, inspiring the next generation of female scientists.

https://lnkd.in/eHAB_qET

#Arecor #WomenInScience and #GirlsInSTEM

Amazing to see the growth and development of Calculus Capital portfolio company Laverock Therapeutics.

Read more: https://lnkd.in/grGcupd4

Metric
Company Name	Calculus VCT plc
Symbol	CLC
MSH ID	COM:CALCULUSCAPITAL
Market	STOCKS
Sector	Financial Services
Industry	Asset Management
Country	GB
Stage
Employee Count
Website	calculuscapital.com/calculus-vct-plc
LinkedIn	calculus-capital
Founders

Metric
Market Cap	518.91K
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	577.52K
Revenue (LTM)
Revenue (NTM)
Gross Profit	577.52K
EBITDA
Operating Income	-629.27K
Net Income	-629.27K
EPS	-0.01
Diluted EPS	-0.01
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	1
Operating Profit Margin	7.45
EBITDA Margin
Net Profit Margin	7.45
Return on Equity	0.01
Return on Assets	0.01
Return on Capital Employed	0.01

COM:CALCULUSCAPITAL

Calculus Capital

Last Close

58.00

21/10 13:32

Market Cap

407.19K

Beta: -

Volume Today

29.96K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	46.19
P/B Ratio	0.87
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	110.00
EV Multiple

Metric
Days Sales Outstanding	51.98
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover	0.03

Metric
Operating Cash Flow	-636.33K
Free Cash Flow	-636.33K
Cash Flow to Debt
Operating Cash Flow/Sales	3.92
Free Cash Flow Yield

Metric
Cash & Equivalents	1.43M
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio	11.39
Quick Ratio	10.99

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue	0.33